Introduction {#s0005}
============

In eukaryotic cells, chromosomal DNA replication requires the formation of a prereplicative complex (pre-RC) on origins, and assembly of other replication proteins in the S phase of the cell cycle to load the DNA polymerases to initiate DNA synthesis [@bib1]. The Cdc45 protein is crucial for the latter step of DNA replication initiation, as it activates the pre-RC that contains the MCM helicase. In addition to these proteins, GINS, a heterotetramer consisting of SLD5, PSF1 (partner of Sld five 1), PSF2, and PSF3 proteins, was recently identified as a loading factor for DNA polymerases, and as being required to separate the DNA strands at the replication fork in yeast and *Xenopus* egg extracts [@bib2], [@bib3], [@bib4], [@bib5], [@bib6]. Although GINS is supposed to play a significant role in eukaryotic cells, the biological functions of its orthologous genes in higher eukaryotes are not fully characterized. A comparative genomic approach for the study of the *GINS* orthologous genes in higher eukaryotes could help in the understanding of a common regulatory mechanism for mammalian *GINS* genes.

In this study, we characterized the human and mouse *GINS* orthologous genes by using bioinformatics techniques. The gene structures, chromosomal localization, protein homology, and expression profiles are discussed. In addition, transcriptional regulations of human and mouse *GINS* genes are characterized. This is the first report of the identification of *GINS* up-regulation by serum stimulation and 17*β*-Estradiol (E2)-stimulated estrogen receptor *α* (ER*α*), and also is the first report that the putative promoter region of human *PSF3* is responsive to transcription factor E2F1.

Results {#s0010}
=======

Characterization of the *GINS* orthologous genes in higher eukaryotes {#s0015}
---------------------------------------------------------------------

To investigate the functional importance of the GINS proteins in higher eukaryotes, we initially compared the amino acid sequences among human, chimpanzee, orangutan, dog, cow, mouse, and rat GINS proteins. As summarized in [Table 1](#t0005){ref-type="table"}, human PSF1, PSF2, PSF3, and SLD5 proteins showed 92%−94%, 86%−100%, 89%−99%, and 84%−88% total amino acid identity, respectively, with the mammalian orthologous genes. Next, we sought to determine the gene structures of the human and mouse *GINS* genes. For this purpose, we searched for a genome database using human and mouse *GINS* cDNAs as query sequences in the BLAST program. Consequently, human (mouse) *PSF1, PSF2, PSF3*, and *SLD5* gene fragments were identified within the genome sequences NT_011387 (AL808125), NT_010498 (AC103360), NT_086851 (AC113951), and NT_086740 (AC126038), respectively. The gene structures, especially the exon length and location of the human and mouse *GINS* genes were well conserved. Human (mouse) *PSF1, PSF2, PSF3*, and *SLD5* genes had 7 (7), 5 (5), 3 (3), and 8 (8) exons, respectively ([Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}). The precise exon-intron boundaries of the human and mouse *GINS* genes were determined based on the consensus sequence ("gt...ag" rule of intronic sequence) of exon-intron junctions and the codon usage. One exception was found in intron2 ("gg...ag") of the human *PSF3* gene ([Table 4](#t0020){ref-type="table"}). The human (mouse) *PSF1, PSF2, PSF3*, and *SLD5* genes were mapped to 20p11.21 (2G3), 16q24.1 (8E1), 16q21 (8C5), and 8p11.21 (8A3), respectively ([Table 6](#t0030){ref-type="table"}).

Expression profiles of human and mouse *GINS* mRNAs {#s0020}
---------------------------------------------------

*In silico* analysis revealed that the expression patterns of the *GINS* mRNA in human/mouse tissues and organs were quite different ([Figure 1A](#f0005){ref-type="fig"}). On the other hand, during the developmental stages, the *GINS* mRNA expression patterns were quite similar: highest in the embryo and juvenile stages, lower in adults, and no expression in the neonatal stage ([Figure 1B](#f0005){ref-type="fig"}). Next, we attempted a search for *GINS* mRNA in public databases. The Gene Expression Omnibus (GEO) database search revealed that the *SLD5* gene is down-regulated under two growth arrest conditions, namely, serum deprivation and contact inhibition, in T98G cancer cells (Accession No. GDS911), and *PSF1* is an estrogen target in human breast carcinoma MCF7 cells (Accession No. GDS118). It is of interest that *GINS* is regulated by serum stimulation, because the mRNA level of a known DNA replication initiator is reported to be induced when cells enter the G1/S phase of the cell cycle [@bib7], [@bib8]. To substantiate this evidence, growth arrest of Saos-2 cells was induced by incubation in serum-free medium for three days, then the cells were re-entered into the cell cycle with the re-addition of 20% fetal bovine serum (FBS). Twenty-four hours after the serum re-addition, the *GINS* mRNA level was found to be up-regulated, while the *GAPDH* mRNA level remained unchanged ([Figure 1C](#f0005){ref-type="fig"}). At this time point, cyclin A protein accumulation was clearly observed as the cells re-entered the cell cycle (data not shown).

Transcriptional regulation of the human and mouse *GINS* genes {#s0025}
--------------------------------------------------------------

To gain more insights into the functions of the human and mouse *GINS* genes, we searched the proximal region of the transcription start site for potential *cis-*elements using the Transfac software (ver. 4.0, cut-off 85). The E2F- and/or NF-Y-binding consensus sequences were identified to be surrounded by GC-rich sequences in the putative promoter region of the human and mouse *GINS* genes ([Figure 2A](#f0010){ref-type="fig"}). In addition to that by serum stimulation, many genes involved in DNA replication initiation were found to be regulated by transcription factor E2F1 [@bib7], [@bib8]. To demonstrate the importance of the putative E2F-binding element in the basal promoter activity, we generated human *PSF1*, mouse *Psf2*, human *PSF3*, and mouse *Sld5* promoter-luciferase constructs. As shown in [Figure 2B](#f0010){ref-type="fig"}, human *PSF1*, mouse *Psf2*, human *PSF3*, and mouse *Sld5* promoter constructs showed approximately 265-, 37-, 0.6-, and 82-fold increases in activity, respectively, as determined by measuring the relative luciferase activities, taking the activity in the control luciferase vector pGL3-Basic as 1. Exogenous coexpression of E2F1 caused up to approximately 1-, 0.2-, 8.3-, and 0.9-fold increases in the human *PSF1*, mouse *Psf2*, human *PSF3*, and mouse *Sld5* promoter activities, respectively, as compared to that of the pcDNA3 control vector ([Figure 2C](#f0010){ref-type="fig"}). These results suggest that the E2F-binding motif plays critical roles in the E2F1-mediated human *PSF3* promoter activity. This is the first report of the E2F1-dependent regulation of the *PSF3* gene.

To determine whether E2 also regulates *GINS* promoter activity, HeLa cells were cultured with E2, and the effect of cotransfection with ER*α* was measured. Interestingly, the initial transient transfection studies with *pGL3-hPSF1, -mPsf2, -hPSF3*, and *-mSld5* reporter vector constructs showed that treatment with 100 nM of E2 resulted in 1.2-, 0.8-, 1.3-, and 0.9-fold increases in the reporter gene activities, respectively, as compared to that after DMSO treatment ([Figure 2D](#f0010){ref-type="fig"}). However, following cotransfection with ER*α*, there was an enhanced (11\~24-fold) induction of reporter gene activity after treatment with 100 nM of E2 as compared to that in the pcDNA3 control vector ([Figure 2D](#f0010){ref-type="fig"}). These results suggest that the *GINS* genes are regulated by E2 via ER*α* in cultured cells.

Discussion {#s0030}
==========

In the present study, we attempted to characterize the gene structure and transcriptional regulation of the human and mouse *GINS* genes. Studies using bioinformatics techniques revealed that the GINS proteins are well conserved among several mammals. In addition, conservation of the gene structure, including the putative promoter region between human and mouse *GINS* genes, suggests that their transcriptional regulation might also be similar. We succeeded in identifying *PSF3* as an E2F1-regulated gene, and that the human and mouse *GINS* genes are regulated by growth stimuli, including serum addition and E2 treatment. In contrast to the rapid progress of research on the yeast and *Xenopus GINS*, only a few reports have been published regarding mammalian *GINS*. For example, mice homozygous for the *PSF1* gene died *in utero* around the time of implantation, indicating that PSF1 protein may be required during early embryogenesis [@bib9]. cDNA microarray analyses revealed that the *PSF2* gene is frequently up-regulated in cholangiocarcinoma, suggesting that PSF2 protein may play an important role in the development of this type of liver cancer [@bib10].

The action of E2 on its target cells is mediated via ER*α* or ER*β*, which function as ligand-activated transcription factors regulating gene expression. E2 has been shown to play a central role in breast cancer development; therefore it is important to find out the critical downstream targets of E2/ERa action. The majority of E2 target genes are characterized by imperfect estrogen-responsive element (ERE: AGGTCANNNTGACCT) sequences or complex organization with the presence of half an ERE site. Interestingly, many E2-responsive genes, which do not contain ERE but do contain other *cis*-elements, such as Spl, have also been described. ERs can regulate transcription by direct protein-protein interaction with Spl [@bib11]. Indeed, the *GINS* promoter constructs used in this study contained GC-rich sequences, but no ERE-like sequences. The mitogenic effect of ER*α* is mediated at the regulation level of kinases that govern the transition from the G0/G1 to S phase of the cell cycle, such as under the influence of cyclin D-Cdk4/6 and cyclin E-Cdk2, to increase phosphorylation of the retinoblastoma protein (pRb) [@bib12]. pRb physically interacts with E2F1 to yield a transcriptionally repressed complex. Phosphorylated pRb results in dissociation of the pRb-E2F1 complex and subsequent up-regulation of E2F1-dependent genes [@bib13], [@bib14], [@bib15]. Although the regulation of E2F1-dependent transactivation is closely linked to pRb, E2 is also known to induce E2F1 mRNA and protein in human cultured cells [@bib16]. This could mean that the E2F1-dependent regulation of *PSF3* expression may be partially mediated by E2. More detailed studies are needed to clearly elucidate the mechanism by which GINS affects the development of breast cancer.

In conclusion, our study clearly demonstrated that a comparative genomic approach for the *GINS* orthologous genes in higher eukaryotes could help in the understanding of common or unique regulatory mechanisms for important genes. We identified the conserved gene structure and for the first time characterized the promoter region of the human and mouse *GINS* genes. This is the first report of the identification of the induction of *GINS* by serum stimulation and E2/ER*α*-induced genes, and is also the first report that human *PSF3* gene is regulated by transcription factor E2F1.

Materials and Methods {#s0035}
=====================

Bioinformatics {#s0040}
--------------

Bioinformatics techniques were employed as previously described [@bib17], [@bib18]. A search for *GINS* orthologous genes was conducted using the HomoloGene or BLAST program at NCBI (<http://www.ncbi.nlm.nih.gov/>). The Transfac software (<http://motif.genome.jp/>) was used to determine the transcription factor binding elements. The search was conducted based on the expression profile suggested by analysis of the EST (expressed sequence tag) counts in human/mouse tissues and organs in the UniGene database (EST Profile Viewer, NCBI). The datasets used for *PSF1, PSF2, Psf3*, and *SLD5* genes were Hs. 360033, Hs. 433180, Mm. 35546, and Hs. 521557, respectively. The number of transcripts per million was calculated based on the gene EST/total EST in the pool, and this value was exported to an Excel file. The expression profile suggested by analysis of Affymetrix GeneChip or SAGE (serial analysis of gene expression) was confirmed by using the GEO database search at NCBI.

Plasmids {#s0045}
--------

The human and mouse *GINS* promoter fragments were generated by polymerase chain reaction (PCR) from genomic DNA and ligated into the pGL3-Basic vector (Promega, Madison, USA). Initial PCR primers were designed to amplify 548 bp (−427/+121), 638 bp (−613/+25), 315 bp (−14/+301), and 499 bp (−409/+90) of human *PSF1* (GenBank Accession No. AL353812), mouse *Psf2* (GenBank Accession No. AC103360), human *PSF3* (GenBank Accession No. AC009118), and mouse *Sld5* (GenBank Accession No. AC147247) promoter sequences, respectively, which are numbered relative to the transcription initiation site at +1 described in the NCBI UniGene database. The forward (F) and reverse (R) PCR primers for the promoter constructs were: 5′-gcagtccctaccagcactag-3′ (−427F), 5′-cggccttgccaaccacca-3′ (+121R), 5′-acccggagctgactttga-3′ (---613F), 5′-gcagcgcctcaggcactt-3′ (+25R), 5′-tcctgtctgatgcgtccc-3′ (−14F), 5′-tgcgctccgctccaggaa-3′ (+301R), 5′-tagagaacaactctgcgc-3′ (−409F), and 5′-agcggtgggcgccggaga-3′ (+90R), respectively. The forward/reverse PCR primers added *Bgl*II/*Hind*III (for *PSF1* and *Sld5)* or *Kpn*I/*Bgl*II (for *Psf2* and *PSF3)* sites to facilitate subcloning. The pcDNA3-HA-E2F1 expression plasmid was a generous gift from Dr. Joseph R. Nevins (Duke University, Durham, USA). The pSG5-ER*α* expression plasmid was kindly provided by Dr. Gary H. Perdew (The Pennsylvania State University, Univeristy Park, USA).

Cell culture and reporter assay {#s0050}
-------------------------------

HeLa and Saos-2 cells were cultured in Earle's modified Eagle's medium (MEM) supplemented with 10% FBS and penicillin/streptomycin. To measure the growth-dependent induction of the human *GINS* gene expression, growth of the Saos-2 cells was arrested in the G0 phase by incubation in the absence of FBS for 3 d, and the cells were reintroduced into the cell cycle by culturing with 20% FBS. Total RNA and cell lysates were recovered at 0 and 24 h after the serum stimulation. To measure promoter activity, the cells were transfected with FuGENE6 (Roche, Indianapolis, USA) according to the manufacturer's instruction. Briefly, 400 ng of expression plasmid, 200 ng of firefly luciferase reporter plasmid (pGL3, Promega), and 0.6 ng of *Renilla* luciferase reporter plasmid (pRL-TK, Promega) per 24-well dish were used in each transfection. After 24 h, cells were treated with 100 nM of E2 (Sigma, St. Louis, USA) or DMSO for 34-40 h. The cells were harvested, and luciferase assay was performed using the Dual-Luciferase Reporter Assay System following the manufacturer's protocol (Promega). Experiments were done at least in triplicate, and the relative activities and S.D. values were determined. To control for transfection efficiency, firefly luciferase values were normalized to the values for *Renilla* luciferase.

RT-PCR {#s0055}
------

Total cellular RNA was extracted from Saos-2 cells using Trizol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instruction. RT-PCR was performed with the SuperScript RT-PCR system according to the manufacturer's instruction (Invitrogen). PCR was performed as follows: denaturation at 94°C for 2 min, followed by multiple cycles at 94°C for 15 s, 55°C for 30 s, and 68°C for 30 s. The following primers were used: PSF1 (GenBank Accession No. NM_021067), 5′-tgagatcacaggcgtgac-3′ and 5′-ctgtccccttccaaagtg-3′; PSF2 (GenBank Accession No. NM_016095), 5′-cagcctctggagagtact-3′ and 5′-cacctctgtgagagagtc-3′; PSF3 (GenBank Accession No. NM_022770), 5′-ctgcctgcagggagttac-3′ and 5′-agagggcccttcatagtc-3′; SLD5 (GenBank Accession No. NM_032336), 5′-gcctctcgccggaagagt-3′ and 5′-cctgacctcatgatccgc-3′. As a control, a GAPDH (glyceraldehyde-3-phosphate dehydrogenase) primer set was used (R&D Systems, Minneapolis, USA). The amplified products were separated on 1% agarose gels and visualized under ultraviolet transillumination.
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![Expression profiles of *GINS* genes. A search was conducted based on the EST counts in human/mouse tissues (**A**) and during the developmental stages (**B**) in the UniGene database (EST Profile Viewer, NCBI). The datasets used for *PSF1, PSF2, Psf3*, and *SLD5* genes were Hs. 360033, Hs. 433180, Mm. 35546, and Hs. 521557, respectively. The number of transcripts per million was calculated from the gene EST/total EST in the pool. **C**. Semi-quantitative RT-PCR analysis of the transcripts of *GINS* genes in Saos-2 cells after serum stimulation for 24 h. The number of PCR cycles is shown in parentheses. The housekeeping gene, *GAPDH*, was used as the control.](gr1){#f0005}

![Transcriptional regulation of the human and mouse *GINS* genes. **A**. Schematic representation of the vicinity of the transcription start sites of the human and mouse *GINS* genes. The putative transcription factor E2F- (closed isosceles triangles) and NF-Y-binding sites (open isosceles triangles) are indicated with their scores (maximum score 100) calculated by the Transfac program. Exon 1 (open boxes) is indicated. Scale bar equals 500 bp. **B**. Human and mouse *GINS* promoter activities in asynchronously growing human cells. HeLa cells were transfected with 200 ng of reporter constructs and 400 ng of the expression vector for E2F1, together with 0.6 ng of pRL-TK. The pcDNA3 vector was used as the negative control. At 48 h after the transfection, the cells were harvested, and extracts were prepared to measure the firefly and *Renilla* luciferase activities. Values are represented as relative luciferase activities, with that of pGL3-Basic being taken as 1. **C**. The E2F-binding motif of the *PSF3* promoter is sufficient to confer responses to ectopic E2F expression. The experiment was performed as described in panel B. Values are represented as relative luciferase activities, with that of the control vector pcDNA3 being taken as 1. Statistically significant *(P \<* 0.05) induction is indicated by an asterisk. **D**. E2-induced activation of *GINS* promoter constructs in HeLa cells. Cells were transfected with the indicated reporter plasmids and pcDNA3 or pSG5-ER*α* expression vector, and the effects of E2 or DMSO on the luciferase activities were determined. Results are expressed as mean±S.D. for at least three triplicate determinations for each treatment group. Statistically significant *(P \<* 0.05) induction is indicated by an asterisk.](gr2){#f0010}

###### 

Conservation of Amino Acids in the GINS Proteins[\*](#tbl1fn1){ref-type="table-fn"}

Table 1

  Mammal       PSF1   PSF2   PSF3   SLD5                     
  ------------ ------ ------ ------ ------ ----- ----- ----- -----
  Human        100    196    100    185    100   216   100   223
  Chimpanzee   92     268    100    185    99    216   --    --
  Orangutan    --     --     --     --     99    216   --    --
  Dog          94     196    94     185    94    216   88    292
  Cow          92     196    86     340    93    216   84    489
  Mouse        92     196    92     185    89    216   87    223
  Rat          93     196    92     434    90    216   88    223

The percentage conservation in mammals, including chimpanzee, orangutan, dog, cow, mouse, and rat proteins relative to the sequence of the human protein (taken as 100%) is presented. The lengths of the amino acid (aa) sequences are indicated. "--" indicates that the protein is not deposited in the databases.

###### 

Exon-Intron Structures of the Human *PSF1* and Mouse *Psf1* Genes[\*](#tbl2fn1){ref-type="table-fn"}

Table 2

  Exon No.   Nucleotide sequence around exon-intron boundaries of human *PSF1* gene   Nucleotide position of exon in human genome sequence   Exon (bp)   Intron (bp)
  ---------- ------------------------------------------------------------------------ ------------------------------------------------------ ----------- -------------
  1          AGCGCG---TTCAAC gtgagg                                                   25328321--25328531 of NT_011387                        211         5,896
  2          ttctag GAGGAT---TGATGT gtaagt                                            25334426--25334490 of NT_011387                        65          3,251
  3          tatcag GAATGA---ATACCT gtaagc                                            25337740--25337838 of NT_011387                        99          904
  4          tcctag GTATGA---GAAGAA gtgagt                                            25338741--25338831 of NT_011387                        91          7,017
  5          ttgcag ATGGAG---ATTGAA gtatgt                                            25345847--25345963 of NT_011387                        117         16,376
  6          tttcag GTCCGG---AGCCAG gtattt                                            25362338--25362412 of NT_011387                        75          4,148
  7          cctcag CACTTT---ATGGAG                                                   25366559--25367702 of NT_011387                        1,144       
                                                                                                                                                         
  Exon No.   Nucleotide sequence around exon-intron boundaries of mouse *Psf1* gene   Nucleotide position of exon in mouse genome sequence   Exon (bp)   Intron (bp)
                                                                                                                                                         
  1          GGAGCT---TTTAAT gtgagg                                                   76468--76660 of AL808125                               193         2,989
  2          tttcag GAGGAC---TGATGT gtaagt                                            79648--79712 of AL808125                               65          3,292
  3          tctcag GAATGA---ATACCT gtgagt                                            83003--82101 of AL808125                               99          1,636
  4          tcctag GTATGA---GAAGAA gtaagt                                            84736--84826 of AL808125                               91          7,924
  5          tcacag ACGGAG---ATTGAA gtatgt                                            92749--92865 of AL808125                               117         2,045
  6          tttcag GTGCGG---AGTCAG gtagtt                                            94909--94983 of AL808125                               75          2,726
  7          ttgtag CACTTT---TTTCAC                                                   97708--98145 of AL808125                               438         

The nucleotide sequences around the exon-intron boundaries are shown in upper-case (exon) and lower-case letters (intron). The exon and intron lengths (bp) are shown.

###### 

Exon-Intron Structures of the Human *PSF2* and Mouse *Psf2* Genes

Table 3

  Exon No.   Nucleotide sequence around exon-intron boundaries of human *PSF2* gene   Nucleotide position of exon in human genome sequence   Exon (bp)   Intron (bp)
  ---------- ------------------------------------------------------------------------ ------------------------------------------------------ ----------- -------------
  1          GCGGCC---ATCGGG gtgagg                                                   39336779--39336614 of NT_010498                        116         1,236
  2          tggcag GGGGAC---ATGTAG gtaagg                                            39335379--39335265 of NT_010498                        115         5,780
  3          ttttag AAAAGT---AAATCA gtaagt                                            39329486--39329387 of NT_010498                        100         2,917
  4          ctttag TGCTTC---GCCAAG gtaggt                                            39326471--39326345 of NT_010498                        127         204
  5          ctttag CTGGAT---AACTCA                                                   39326142--39325479 of NT_010498                        664         
                                                                                                                                                         
  Exon No.   Nucleotide sequence around exon-intron boundaries of mouse *Psf2* gene   Nucleotide position of exon in mouse genome sequence   Exon (bp)   Intron (bp)
                                                                                                                                                         
  1          GGGAAA---ATCGGG gtgagc                                                   111624--111788 of AC103360                             165         88
  2          ttgcag GGGGAC---ATGTGG gtgagc                                            111875--111989 of AC103360                             115         2,534
  3          tcagag AGAAAC---GAATCA gtgagt                                            114522--114621 of AC103360                             100         3,886
  4          cttcag TGCTTC---GCCAAG gtaggc                                            118506--118632 of AC103360                             127         272
  5          tttcag CTGGAC---TATACT                                                   118903--122081 of AC103360                             3,179       

###### 

Exon-Intron Structures of the Human *PSF3* and Mouse *Psf3* Genes

Table 4

  Exon No.   Nucleotide sequence around exon-intron boundaries of human *PSF3* gene   Nucleotide position of exon in human genome sequence   Exon (bp)   Intron (bp)
  ---------- ------------------------------------------------------------------------ ------------------------------------------------------ ----------- -------------
  1          CCGCTT---CCACAG gtgagc                                                   2010301--2010569 of NT_086851                          269         9,759
  2          ctgcag GGTTCC---CTGCAG ggcaag                                            2020327--2020560 of NT_086851                          234         1,169
  3          tcccag ACTTTT---TTAGCA                                                   2021728--2023378 of NT_086851                          1,651       
                                                                                                                                                         
  Exon No.   Nucleotide sequence around exon-intron boundaries of mouse *Psf3* gene   Nucleotide position of exon in mouse genome sequence   Exon (bp)   Intron (bp)
                                                                                                                                                         
  1          GAGTTT---CCTCAG gtgagg                                                   126499--126244 of AC113951                             256         4,028
  2          acgcag GGTACA---CTGAAG gtaagt                                            122217--121984 of AC113951                             234         5,061
  3          cctcag ACTTTT---GCCTGC                                                   116924--115517 of AC113951                             1,407       

###### 

Exon-Intron Structures of the Human *SLD5* and Mouse *Sld5* Genes

Table 5

  Exon No.   Nucleotide sequence around exon-intron boundaries of human *SLD5* gene   Nucleotide position of exon in human genome sequence   Exon (bp)   Intron (bp)
  ---------- ------------------------------------------------------------------------ ------------------------------------------------------ ----------- -------------
  1          GCGACT---CCCCGA gtgagc                                                   28874824--28874993 of NT_086740                        170         789
  2          cattag GTTCCT---GAGCAG gtaagc                                            28875781--28875895 of NT_086740                        115         6,063
  3          ttttag GCCTGG---CACATG gtaaga                                            28881957--28882043 of NT_086740                        87          735
  4          taatag GAAGAA---ATGAAG gtttga                                            28882777--28882890 of NT_086740                        114         2,436
  5          tcacag ATAGAG---CAGAGA gtgagt                                            28885325--28885422 of NT_086740                        98          142
  6          tttcag GTTCAT---GGGCAG gtaaac                                            28885563--28885651 of NT_086740                        89          1,851
  7          tggcag TTCCCA---GCAGAG gtgagt                                            28887501--28887591 of NT_086740                        91          93
  8          tttcag GGACTA---AAAAAA                                                   28887683--28888085 of NT_086740                        403         
                                                                                                                                                         
  Exon No.   Nucleotide sequence around exon-intron boundaries of mouse *Sld5* gene   Nucleotide position of exon in mouse genome sequence   Exon (bp)   Intron (bp)
                                                                                                                                                         
  1          GTGTTT---TGCGAG gtgagc                                                   79323--79134 of AC126038                               190         372
  2          tttcag GTGTAG---GAGCAG gtaagc                                            78763--78644 of AC126038                               120         2,141
  3          ttttag GCCTGG---CACATG gtaaga                                            76504--76418 of AC126038                               87          2,037
  4          taatag GAAGAA---ATGAAG gtttga                                            74382--74269 of AC126038                               114         2,903
  5          tcacag ATAGAG---CAAAGA gtaagt                                            71367--71270 of AC126038                               98          103
  6          ttccag GTATAT---GGGCAG gtaaga                                            71168--71080 of AC126038                               89          2,078
  7          tggcag TTCCCA---GCAGAG gtgagt                                            69003--68913 of AC126038                               91          75
  8          tttcag AGACTA---AAGCTT                                                   68839--68289 of AC126038                               501         

###### 

Chromosomal Localization of the Human and Mouse *GINS* Genes

Table 6

          *PSF1*     *PSF2*    *PSF3*   *SLD5*
  ------- ---------- --------- -------- ---------
  Human   20p11.21   16q24.1   16q21    8p11.21
  Mouse   2G3        8E1       8C5      8A3
